SEC Filing Summary: SPACEHAB, Incorporated (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by SPACEHAB, Incorporated on August 10, 2007, reporting an event that occurred on August 7, 2007. The registrant is headquartered in Webster, Texas. The filing addresses a regulatory compliance issue with The NASDAQ Stock Market regarding board composition.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding corporate governance and listing status, not a financial statement.
Material Changes
The material change reported is the loss of compliance with NASDAQ Marketplace Rule 4350(c)(1). This non-compliance resulted from the resignation of Dr. Edward E. David Jr. as a director, effective July 31, 2007. Consequently, the company no longer maintains a majority of independent directors on its board of directors as required by the exchange.
Outlook, Risks, and Contingencies
Cure Period: NASDAQ has granted the company a cure period to regain compliance. The deadline is the earlier of the next annual shareholders' meeting or July 31, 2008. If the next annual meeting occurs before January 28, 2008, compliance must be evidenced by that date.
Risk of Delisting: If the company fails to regain compliance within the specified cure period, its common stock is subject to delisting from NASDAQ. The company may appeal any determination of delisting.
Management Action: The company issued a press release on August 10, 2007, to announce this event in compliance with Marketplace Rule 4803(a).
Key Facts for Investor Verification
- Verify the current composition of the Board of Directors to confirm if the independent director requirement has been met.
- Monitor the date of the next annual shareholders' meeting to determine the exact deadline for regaining compliance.
- Check for any subsequent filings regarding the status of the cure period or potential delisting notices.
- Review the attached press release (Exhibit 99.1) for additional management commentary on the resignation and remediation plan.